GUAIFENESIN DAC ORAL SOLUTION | Guaifenesin DAC
Alcohol 1.9%, artificial cherry flavor, caramel, citric acid, disodium edetate, FD&C Red #40, glycerin, menthol, purified water, saccharin sodium, sodium benzoate, sorbitol solution.
Temporarily relieves cough and nasal congestion as may occur with a cold. Helps loosen phlegm (mucus) and thin bronchial secretions to make coughs more productive.
Take every 4 hours or as directed by a doctor. Do not exceed 4 doses in 24 hours. Adults and children 12 years of age and over: Take 2 teaspoons. Children 6 to under 12 years of age: Give 1 teaspoon. Children under 6 years of age: Do not use. Giving a higher dose than recommended by a doctor could result in serious side effects for your child.
Do not exceed recommended dosage.
Do not take this product if you have heart disease, high blood pressure, thyroid disease, diabetes, or difficulty in urination due to enlargement of the prostate gland unless directed by a doctor. Adults and children who have a chronic pulmonary disease or shortness of breath, or children who are taking other drugs, should not take this product unless directed by a doctor. Do not take this product for persistent or chronic cough such as occurs with smoking, asthma, chronic bronchitis, or emphysema, or if cough is accompanied by excessive phlegm (mucus) unless directed by a doctor. A persistent cough may be a sign of a serious condition. If cough persists for more than 1 week, tends to recur, or is accompanied by fever, rash, or persistent headache, consult a doctor. If nervousness, dizziness, or sleeplessness occur, discontinue use and consult a doctor. If symptoms do not improve within 7 days or are accompanied by fever, consult a doctor. May cause or aggravate constipation. As with any drug, if you are pregnant or nursing a baby, seek the advice of a health professional before using this product.
Keep this and all drugs out of the reach of children. In case of accidental overdose, seek professional assistance or contact a Poison Control Center immediately.
Do not use this product if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric or emotional conditions, or Parkinson's disease), or for 2 weeks after stopping the MAOI drug. If you are uncertain whether your prescription drug contains a MAOI, consult a health professional before taking this product.
Dispense in a tight, light-resistant container as defined in the USP.
Store at controlled room temperature 20°-25°C (68°-77°F). (see USP Controlled Room Temperature) DO NOT REFRIGERATE.
Each 5 mL contains: sodium 4 mg.
Do not use this product if inner foil seal over the mouth of the bottle is cut, torn, broken or missing.
| BULK CONTAINER - NOT FOR HOUSEHOLD USE. |
NDC 16571-301-16TAMPER-EVIDENT DO NOT REFRIGERATE
GUAIFENESIN DAC ORAL SOLUTION CV
EXPECTORANTNASAL DECONGESTANTCOUGH SUPPRESSANT
Each teaspoon (5 mL) Contains: Guaifenesin USP 100 mgPseudoephedrine Hydrochloride USP 30 mgCodeine Phosphate USP 10 mgcontains 1.9% alcohol v/v
*Under Federal law Guaifenesin DACis available without a prescription.Certain State laws may differ.
Manufactured by:Bio-Pharm, Incorporated Levittown, PA 19057Distributed by: PACK PHARMACEUTICALS, LLC Buffalo Grove, IL 60089 REV 08/09
TO REPORT ADVERSE DRUG EVENTS CALL: (866) 562-4597
ONE PINT (473 mL)
PACK PHARMACEUTICALS, LLC

Manufacturer
Pack Pharmaceuticals LLC
Active Ingredients
Source
- U.S. National Library of Medicine
- DailyMed
- Last Updated: 4 May 2013
Drugs and Medications
Guaifenesin dm [Pharmaceutical Associates, Inc.]
Maximum Strength Guaifenesin DM Non-Narcotic, Sugar and Alcohol Free Expectorant/Cough Suppressant
Guaifenesin [Contract Pharmacy Services-PA]
Guaifenesin
Mucinex dm [Reckitt Benckiser LLC]
Mucinex®DM
Mucinex dm [Physicians Total Care, Inc.]
Mucinex®DM
Sinus congestion pe [Rite Aid]
Rite Aid 44-542
Clinical Trials
Patients with allergic rhinitis frequently present exacerbation of the atopic symptoms during viral infections of the upper respiratory tract. Also, allergic rhinitis makes the mucosa more...
A Methodology Study to Assess Cough Counts in Subjects With Acute Upper Respiratory Tract Infections
The objectives of this study are: a) to assess the feasibility and sensitivity of manually count cough bouts over a 4-hour period; b) to assess the effects of buckwheat honey and guaifenes...
It is believed that the suppository consisting of guaiacol, menthol, camphor and eucalyptol, by their pharmacological properties already established for each component, has the ability to...
This study will compare the symptom relief provided by 5 cold medicines versus the symptom relief provided by the same 5 cold medicines plus the antibiotic, amoxicillin, in people who have...
This is a multicenter, randomized, blinded, placebo-controlled study of Mucinex in patients with colds. Patients will receive 7 days of treatment with either Mucinex or placebo. The stud...
PubMed Articles
Anesthetic induction with guaifenesin and propofol in adult horses.
Objective-To evaluate whether guaifenesin can prevent adverse anesthetic induction events caused by propofol and whether a guaifenesin-propofol induction combination has brief cardiovascular effects c...
New, simple, rapid and precise reversed phase liquid chromatographic (RP-LC) method has been developed for the simultaneous determination of diclofenac potassium (DP) and methocarbamol (MT) in ternary...
A simple and rapid analytical procedure was proposed for the determination of chromatographic peaks by means of partial least squares multivariate calibration (PLS) of high-performance liquid chromato...
The interactions of metoprolol tartrate (MPT) and guaifenesin (GF) drugs with human serum albumin (HSA) and human hemoglobin (HMG) proteins at pH 7.4 were studied by fluorescence and circular dichro...
Optimization of an improved single-column chromatographic process for the separation of enantiomers.
This work addresses optimization of an improved single-column chromatographic (ISCC) process for the separation of guaifenesin enantiomers. Conventional feed injection and fraction collection systems...